EPAM Q2 Showed 22% EPS Growth-But Lower Guidance Made This a Hold, Not a Chase

EPAM's Q2 verdict: stronger profits, softer growth

EPAM's second quarter was a profitability story first and a growth story second. That is why the stock still looks more like a hold than a chase.

The headline strength was real: 22.0% non-GAAP EPS growth and better margins stand out. But the broader signal is more mixed. Revenue grew 4.5% year over year, and management cut full-year revenue growth to 3.2%-4.2% from 4.0%-6.5%. For now, that points to a company improving earnings quality before it reaccelerates growth.

Q2 improved margins, but growth still depends on AI converting

Profitability improved for real reasons

Q2 was not a accounting gimmick. Non-GAAP gross margin rose to 32.0% from 30.1%, and management attributed that improvement to price increases and better fixed-fee profitability. That suggests EPAM still had some pricing power while getting better at earning more from contracted work.

That improvement carried through to operating profit. GAAP operating margin increased to 10.8% from 9.3%, and non-GAAP operating margin rose to 16.4% from 15.0%. EPAM delivered more profit per dollar of revenue, which is genuine operating progress.

AI demand is visible, but not broad enough yet

AI is already contributing to the mix. EPAM reported $160 million in AI-native revenue, and the company has now posted several quarters of double-digit sequential growth in that bucket. That matters because it shows AI is already part of current revenue, not just a future pitch.

But the broader revenue base still has drag. Financial Services grew 11.5% and Life Sciences and Healthcare grew 8%, while Software & Hi-Tech declined 1.3% due to project ramp-downs in non-AI services. In other words, AI demand is helping, but it is not yet offsetting weakness everywhere else.

That keeps this setup closer to an efficiency story with AI optionality than a clean growth rerating.

The main cap on the stock is timing, not relevance

Why management lowered guidance

The quarter itself was not broken. Revenue came in at $1.415 billion, up from $1.400 billion in Q1, and organic constant-currency growth was 3.4%. This was not a sudden demand collapse.

The issue was timing. Client spending is shifting, but the sales engine has not fully converted that shift into booked growth yet. That shows up most clearly by geography. Americas revenue grew only 0.5% year over year, while EMEA grew 10.9%. Because North America is 57% of total revenue, that regional split is important.

That is also why full-year organic growth guidance fell to 2.0%-3.0% from 2.5%-5.0%. Even with AI-native revenue already contributing, management made clear on the call that larger AI-led deals should help more in 2027 than in a sharp 2026 rerating.

What to watch in the next quarter

The next print needs to answer two questions: - Is revenue guidance holding steady instead of moving lower? - Are margins still supported as growth stabilizes?

If both happen, investors can start to argue that the timing problem is clearing. If guidance slips again, the bottom has likely not arrived.

What would change the story

The bullish trigger

The stock becomes more interesting if execution starts to close the gap with the AI narrative. The simplest near-term sign is stable guidance and steady margins. That would suggest EPAM is moving from a reset phase to a recovery phase.

What would invalidate the thesis

This setup gets weaker if North America lagged remains the theme into the next update. North America is the key demand test because Americas Revenue grew only 0.5%. If that region stays soft, the commercial bridge is still not holding.

For now, EPAM still looks like a watchlist recovery story rather than an immediate buy-off-the-headlines setup.